<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01032876</url>
  </required_header>
  <id_info>
    <org_study_id>08-090/K</org_study_id>
    <nct_id>NCT01032876</nct_id>
  </id_info>
  <brief_title>Cerebral Perfusion During Neonatal Cardiac Surgery</brief_title>
  <official_title>Randomized Controlled Trial on Deep Hypothermic Circulatory Arrest Versus Antegrade Cerebral Perfusion During Neonatal Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>UMC Utrecht</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neonates with a congenital heart defect are often in need of early cardiac surgery. In
      complex congenital heart defects, cardiopulmonary bypass is usually employed, with or without
      deep hypothermic circulatory arrest (DHCA). The brain is especially vulnerable to ischemic
      injury, which puts neonates undergoing complex operations at high risk of neurodevelopmental
      disorders. Selective antegrade cerebral perfusion (ACP) instead of DHCA during these complex
      operations may contribute to less cerebral damage, but literature is not conclusive on this
      issue.

      Therefore, the investigators will perform a randomised controlled trial comparing DHCA and
      ACP in neonatal aortic arch reconstructions, focusing on cerebral damage and neurological
      outcome.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>New or worsened lesions on postoperative MRI-scan (as compared to pre-operative scan).</measure>
    <time_frame>Approximately 1 week postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality within 30 days</measure>
    <time_frame>30 days postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Congenital Heart Defects</condition>
  <condition>Hypoplastic Left Heart Syndrome</condition>
  <condition>Aortic Coarctation</condition>
  <arm_group>
    <arm_group_label>Deep Hypothermic Circulatory Arrest</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Antegrade Cerebral Perfusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Deep Hypothermic Circulatory Arrest</intervention_name>
    <description>DHCA will be employed for a maximum of 60 minutes. If more time (&gt;60 min) is needed for the arch reconstruction the surgeon will proceed with ACP, which will be continued for the rest of the operation (= DHCA+ACP).</description>
    <arm_group_label>Deep Hypothermic Circulatory Arrest</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Antegrade Cerebral Perfusion</intervention_name>
    <description>One cannula will be advanced into the brachiocephalic/ innominate artery via the usual arterial cannulation site in the aorta ascendens. A flow of 20-25% of the maximum CPB-flow will be used, which corresponds to a flow rate of 40-50 ml/ kg/ min.</description>
    <arm_group_label>Antegrade Cerebral Perfusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aortic arch reconstruction (diagnosis of hypoplastic left heart syndrome, hypoplastic
             aortic arch, severe coarctation and/ or interrupted aortic arch)

          -  Infants &lt;4 months old

        Exclusion Criteria:

          -  Anticipated arch reconstruction time longer than 60 minutes

          -  Sedation and intubation especially for the pre-operative MRI-scan of this research
             project

          -  Participation in another clinical trial

          -  Failure of data collection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felix Haas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UMC Utrecht</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2009</study_first_submitted>
  <study_first_submitted_qc>December 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2009</study_first_posted>
  <last_update_submitted>June 28, 2012</last_update_submitted>
  <last_update_submitted_qc>June 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2012</last_update_posted>
  <responsible_party>
    <name_title>Prof. F. Haas</name_title>
    <organization>UMC Utrecht</organization>
  </responsible_party>
  <keyword>Congenital Heart disease</keyword>
  <keyword>Cardiopulmonary bypass</keyword>
  <keyword>Neonatal brain injury</keyword>
  <keyword>Deep Hypothermic Circulatory Arrest</keyword>
  <keyword>Antegrade Cerebral Perfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Defects, Congenital</mesh_term>
    <mesh_term>Hypoplastic Left Heart Syndrome</mesh_term>
    <mesh_term>Aortic Coarctation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

